Use Able AI chat for product recommendations

Recombinant Human NKG2C/CD159c protein (rFc Tag)

Species

Human

Purity

>90 %, SDS-PAGE

Tag

rFc Tag

Activity

not tested

Cat no : Eg2639



Product Information

Purity >90 %, SDS-PAGE
Endotoxin <0.1 EU/μg protein, LAL method
Activity
Not tested
Expression HEK293-derived Human NKG2C protein Ile94-Leu231 (Accession# P26717) with a rabbit IgG Fc tag at the C-terminus.
GeneID 3822
Accession P26717
PredictedSize 41.8 kDa
SDS-PAGE 45-60 kDa, reducing (R) conditions
Formulation Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
Reconstitution Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
Storage Conditions
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

Background

NKG2C, also known as KLRC2 and CD159c, is an activating receptor of natural killer (NK) cells and plays a significant role in immune surveillance and host resistance against viruses and tumors (PMID: 36899273). It is an immune activating receptor involved in self-nonself discrimination. In complex with KLRD1 on cytotoxic lymphocyte subsets, recognizes non-classical major histocompatibility (MHC) class Ib HLA-E loaded with signal sequence-derived peptides from non-classical MHC class Ib HLA-G molecules, likely playing a role in the generation and effector functions of adaptive natural killer (NK) cells and in maternal-fetal tolerance during pregnancy (PMID: 30134159; 37264229; 9754572).

References:

1. Siemaszko J. et al. (2023). Arch Immunol Ther Exp (Warsz). 71(1):9. 2. Rölle A. et al. (2018). Cell Rep. 24(8):1967-1976.e4. 3. Lin Z. et al. (2023). Nat Immunol. 24(7):1087-1097. 4. Llano M. et al. (1998). Eur J Immunol. 28(9):2854-2863.

||
New chat

Able™

正在加载,请稍候...